MML Investors Services’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $327K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $391K | Sell |
|
|||||
|
2024
Q1 | $618K | Sell |
|
|||||
|
2023
Q4 | $752K | Sell |
|
|||||
|
2023
Q3 | $1.12M | Buy |
|
|||||
|
2023
Q2 | $1.16M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $613K | Buy |
|
|||||
|
2022
Q3 | $873K | Buy |
|
|||||
|
2022
Q2 | $722K | Buy |
|
|||||
|
2022
Q1 | $410K | Buy |
|
|||||
|
2021
Q4 | $334K | Sell |
|
|||||
|
2021
Q3 | $611K | Buy |
|
|||||
|
2021
Q2 | $840K | Buy |
|
|||||
|
2021
Q1 | $489K | Sell |
|
|||||
|
2020
Q4 | $641K | Buy |
|